Matthew Sykes

May 06, 2025

Target

$48.00

Current

$127.22

Performance

288.46%

Matthew Sykes rated TWST as Buy on May 06, 2025, setting a price target of 48. The call has proven timely, with shares rising 288.46% toward the price target of 48.

RVTY

Apr 29, 2025

Target

$125.00

Current

$124.31

Performance

31.32%

On Apr 29, 2025, RVTY was given a Buy rating by Matthew Sykes, with a target price of 125. The stock rallied 31.32% after the rating, narrowing the gap to the target of 125 and validating the bullish stance.

ICLR

Mar 21, 2025

Target

$200.00

Current

$169.31

Performance

-8.42%

ICLR received a Neutral rating from Matthew Sykes on Mar 21, 2025, aiming for 200. The Hold stance proved prudent, with the market softening by 8.42%.

CRL

Mar 21, 2025

Target

$170.00

Current

$278.26

Performance

66.34%

On Mar 21, 2025, Matthew Sykes published a Neutral outlook on CRL, with a target of 170. The Hold call missed some of the bullish momentum as shares advanced toward 170.

FTRE

Mar 04, 2025

Target

$11.00

Current

$17.20

Performance

56.93%

Matthew Sykes on Mar 04, 2025 assigned FTRE a Neutral rating, with a price target of 11. Shares outperformed expectations, climbing 56.93% despite the neutral view.

GH

Feb 21, 2025

Target

$56.00

Current

$157.38

Performance

267.11%

On Feb 21, 2025, Matthew Sykes reaffirmed GH with a Buy rating, targeting 56. The recommendation was supported by strong follow-through as the stock rose from 157.38 to 157.38.

WGS

Feb 19, 2025

Target

$80.00

Current

$85.27

Performance

-23.40%

WGS was rated Neutral by Matthew Sykes on Feb 19, 2025, with a price objective of 80. Investors who stayed cautious avoided some of the 23.40% decline.

PACB

Feb 18, 2025

Target

$1.50

Current

$1.30

Performance

-30.48%

On Feb 18, 2025, Matthew Sykes initiated coverage on PACB with a Neutral rating and target of 1.5. The rating matched the stock’s inability to hold above 1.3.

NEO

Jan 28, 2025

Target

$18.00

Current

$17.32

Performance

14.10%

Matthew Sykes issued a Buy recommendation for NEO on Jan 28, 2025, price target set at 18. Investors following the Buy call captured upside momentum, with shares now at 17.32.

NTRA

Jan 28, 2025

Target

$190.00

Current

$328.93

Performance

95.70%

On Jan 28, 2025, NTRA was evaluated by Matthew Sykes, who gave a Buy rating and target of 190. This case illustrates how a timely bullish rating can translate into tangible gains of 95.70%.

MYGN

Jan 28, 2025

Target

$18.00

Current

$3.42

Performance

-72.64%

Matthew Sykes rated MYGN as Buy on Jan 28, 2025, setting a price target of 18. The stock has underperformed, dropping 72.64% despite the bullish target of 18.

VCYT

Dec 05, 2024

Target

$37.00

Current

$40.87

Performance

-4.60%

On Dec 05, 2024, VCYT was given a Neutral rating by Matthew Sykes, with a target price of 37. Market indecision, reflected in sideways trading near 40.87, supported the cautious call.

BRKR

Dec 05, 2024

Target

$60.00

Current

$53.43

Performance

-8.64%

BRKR received a Neutral rating from Matthew Sykes on Dec 05, 2024, aiming for 60. The Hold stance proved prudent, with the market softening by 8.64%.

NAUT

Dec 05, 2024

Target

$1.75

Current

$1.02

Performance

-46.87%

On Dec 05, 2024, Matthew Sykes published a Sell outlook on NAUT, with a target of 1.75. The Sell recommendation underestimated bullish momentum toward 1.75.

MRVI

Dec 05, 2024

Target

$4.25

Current

$6.53

Performance

28.29%

Matthew Sykes on Dec 05, 2024 assigned MRVI a Sell rating, with a price target of 4.25. The market validated the bearish call with a pullback to 6.53.

CDNA

Oct 16, 2024

Target

$35.00

Current

$50.26

Performance

91.98%

On Oct 16, 2024, Matthew Sykes reaffirmed CDNA with a Buy rating, targeting 35. The recommendation was supported by strong follow-through as the stock rose from 50.26 to 50.26.

DHR

Jul 24, 2024

Target

$250.00

Current

$200.06

Performance

-24.72%

DHR was rated Neutral by Matthew Sykes on Jul 24, 2024, with a price objective of 250. Investors who stayed cautious avoided some of the 24.72% decline.

EXAS

Jul 17, 2024

Target

$75.00

Current

$104.91

Performance

112.50%

On Jul 17, 2024, Matthew Sykes initiated coverage on EXAS with a Buy rating and target of 75. The stock’s climb of 112.50% since the call highlights the foresight in the rating.

TXG

Jul 09, 2024

Target

$16.00

Current

$68.59

Performance

275.84%

Matthew Sykes issued a Sell recommendation for TXG on Jul 09, 2024, price target set at 16. The bearish outlook played out, as shares fell from 68.59 to 68.59.

OMIC

Jul 09, 2024

Target

$6.50

Current

$20.01

Performance

162.60%

On Jul 09, 2024, OMIC was evaluated by Matthew Sykes, who gave a Neutral rating and target of 6.5. Investors who stayed in despite the Hold saw upside of 162.60%.

QTRX

Jul 09, 2024

Target

$24.00

Current

$2.56

Performance

-79.76%

Matthew Sykes rated QTRX as Buy on Jul 09, 2024, setting a price target of 24. The stock has underperformed, dropping 79.76% despite the bullish target of 24.

MTD

Jul 09, 2024

Target

$1300.00

Current

$1293.52

Performance

-1.11%

On Jul 09, 2024, MTD was given a Neutral rating by Matthew Sykes, with a target price of 1300. Market indecision, reflected in sideways trading near 1293.52, supported the cautious call.

DNA